The regulation of choline kinase (EC 2.7.1.32), the initial enzyme in the CDP-choline pathway, was examined in Saccharomyces cerevisiae. The addition of myo-inositol to a culture of wild-type cells resulted in a significant decrease in choline kinase activity. Additional supplementation of choline caused a further reduction in the activity. The coding frame of the choline kinase gene, CKI, was joined to the carboxyl terminus of lacZ and expressed in Escherichia coli as a fusion protein, which was then used to prepare an anti-choline kinase antibody. Upon Western (immuno-) and Northern (RNA) blot analyses using the antibody and a CKI probe, respectively, the decrease in the enzyme activity was found to be correlated with decreases in the enzyme amount and mRNA abundance. The molecular mass of the enzyme was estimated to be 66 kilodaltons, in agreement with the value predicted previously from the nucleotide sequence of the gene. The coding region of CKI was replaced with that of lacZ, and CKI expression was measured by assaying ,-galactosidase. The expression of j-galactosidase from this fusion was repressed by myo-inositol and choline and derepressed in a time-dependent manner upon their removal. The present findings indicate that yeast choline kinase is regulated by myo-inositol and choline at the level of mRNA abundance.
The cooperation of myo-inositol (inositol) and choline in the control of phospholipid synthesis in the yeast Saccharomyces cerevisiae was first demonstrated for the enzymes in the phosphatidylethanolamine methylation pathway (38) . Thereafter, a number of enzymes involved in the synthesis of phospholipids were shown to be subject to regulatory changes in response to inositol and choline. These changes include inhibition of phosphatidylserine synthase (20) , induction of phosphatidate phosphatase (28) , and inactivation or degradation of phosphatidylglycerophosphate synthase (10) , but a more general response is the coordinate repression of phospholipid-synthesizing enzymes, such as CDPdiacylglycerol synthase (13, 14) , phosphatidylserine synthase (1, 5, 13, 22, 31) , phosphatidylserine decarboxylase (6) , phosphatidylethanolamine methyltransferase (22, (35) (36) (37) , phospholipid methyltransferase (38) , and inositol-1-phosphate synthase (7, 8, 12) . The activities of these enzymes are considerably reduced when cells are cultured in the presence of inositol alone, but maximum reductions occur in the presence of both inositol and choline. The decreases in the activities have been correlated with decreases in the enzyme amounts in the cases of CDP-diacylglycerol synthase (13) , phosphatidylserine synthase (13, 31) , and inositol-1-phosphate synthase (8) . Furthermore, in the case of phosphatidylserine synthase (1), inositol-1-phosphate synthase (12) , phosphatidylethanolamine methyltransferase, and phospholipid methyltransferase (23; T. Kodaki, unpublished results) , it has been shown that decreases in mRNA abundance are associated with changes in enzyme activities and amounts.
In the present study, we investigated the effects of inositol and choline on the CDP-choline pathway, whose regulation had not previously been extensively studied for S. cerevisiae. We show here that the addition of inositol and choline to the growth medium caused repression of the initial enzyme, choline kinase. The other two enzymes, cholinephos-* Corresponding author. phate cytidylyltransferase and cholinephosphotransferase, were not significantly affected. Using the choline kinase gene, CKI (16), we prepared a ,B-galactosidase-choline kinase fusion protein and raised an anti-choline kinase antibody. Western (immuno-) blot analysis demonstrated reduction of the enzyme amount occurring in response to inositol and choline. This reduction was correlated with a decrease in mRNA abundance by Northern (RNA) blot analysis. The present report is the first demonstration of the control of the CDP-choline pathway in yeast and shows that choline kinase is coordinately regulated with other key enzymes in phospholipid synthesis.
MATERIALS AND METHODS
Yeast strains and culture. Wild-type strains X2180-1A (a SUC2 mal mel gal2 CUPI) and X2180-1B (a SUC2 mal mel gal2 CUPI) were provided by the Yeast Genetic Stock Center (University of California). AH22 (a leu2-3 leu2-112 his4-519 canl) and C5014-2B (a ura3 arg9 hom3 hisi) were obtained from N. Gunge (Kumamoto Institute for Technology). D302-2 (ot leu2-3 leu2-112 his4-519 canl) and D302-3C (a leu2-3 leu2-112 his4-519 cani) were derived from a cross of AH22 with X2180-1B. D395-2 (a leu2-3 leu2-112) was derived from a cross of D302-2 with X2180-1A. Strain 2014 (a leu2-3 leu2-112 his4-519 can] cki::LEU2) was constructed previously (16) and used as the choline kinase gene disruptant. D448-2 (a ura3 can]) was derived from a cross of C5014-2B with D395-2. D451-3 (a leu2-3 leu2-114 ura3 canl) was constructed by crossing D448-2 with D302-3C. The composition of inositol-depleted minimal medium (M-i) was as described previously (37 (16, 17, 30) . ,-Galactosidase was assayed at 30°C by measuring the increase in A420 with o-nitrophenyl-D-galactoside as the substrate after the cells had been permeabilized by treatment with chloroform and sodium dodecyl sulfate, as described by Miller (27) Affinity purification of an anti-choline kinase antibody.
Unless otherwise stated, all incubations were carried out at room temperature on a TAITEC R-30 mini rotary shaker (Taiyo Scientific, Tokyo, Japan). A nitrocellulose membrane (2 by 6 cm) was soaked in 3 ml of 75 mM potassium phosphate buffer (pH 7.4) containing 2.5 mg of the choline kinase obtained above and then incubated for 4 h. The membrane was transferred to 10 ml of 20 mM Tris hydrochloride buffer (pH 7.5)-0.15 M NaCl (TBS) containing 10% (wt/vol) dried milk (Yukijirushi, Sapporo, Japan) for 1 h and then rinsed with four changes of 10 ml of TBS for a total period of 20 min. The treated membrane was cut into 12 pieces (0.5 by 2 cm each), which were kept wet with TBS at 4°C until used. Four pieces were placed in 5 ml of 10- fold-diluted anti-choline kinase serum in TBS, incubated for 1 h, and then washed four times with TBS, from which the choline kinase antibody was eluted with 0.8 ml of 1 M propionic acid at 4°C. The eluate was immediately neutralized with 0.4 ml of 2 M Tris containing 3% (wt/vol) bovine serum albumin, dialyzed against 1 liter of TBS at 4°C for 3 h, and used immediately.
Immunoblotting. Cell extracts were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis on a 10% gel by the method of Laemmli (24) . The protein bands were transferred to a nitrocellulose membrane (Hybond-C) with a Semi Dry Electroblotter (Sartorius, Gottingen, Federal Republic of Germany). The membrane was treated with 10% (wt/vol) dried milk in TBS to block nonspecific binding at 4°C overnight and then with the affinity-purified anti-choline kinase antibody diluted 1 to 2 for 1 h, followed by extensive rinsing with TBS and treatment for 1 h with the protein A-peroxidase complex (Zymed Laboratories, San Francisco, Calif.) diluted 1 to 2,500. Immunoreactive proteins were located by staining with an Immunostaining HRP Kit IS-SOB (Konica, Tokyo, Japan).
Northern blot analysis. Poly(A)+ RNA was isolated as described by Kataoka et al. (19) from wild-type yeast X2180-1B cells cultured under the indicated conditions, separated by formaldehyde-agarose gel electrophoresis (26) , and then transferred to a Biodyne A membrane (Nihon Pole, Tokyo, Japan). Hybridization was performed with multiprime-labeled probes according to the instruction manual of the manufacturer. The membrane was washed, dried, and then autoradiographed by using Fuji RX X-ray film.
Construction (29), contained the E. coli ampicillin resistance gene, the multicloning site of pUC18 (39) , the yeast LEU2 gene (32) , and the 2,um replication origin (11) (18) .
RESULTS
Effects of inositol and choline on the activity level of choline kinase. In the course of enzymic studies, we noticed a considerable difference in choline kinase activity between cells grown in rich medium and those grown in minimal medium. Investigations in our laboratory (37, 38) and others (1, 5-7, 8, 12, 13, 22, 31, 35, 36) showed that in S. cerevisiae a number of enzymes involved in phospholipid synthesis are regulated in a coordinated manner in response to inositol and choline supplementation. Although our previous study suggested that yeast choline kinase is constitutive (37), we decided to reinvestigate the possibility that choline kinase is also under the control of inositol and choline.
The wild-type yeast was grown in M-i medium supplemented with different concentrations of inositol and choline and harvested at the mid-logarithmic phase, and then choline kinase activity was determined. The addition of inositol and choline to the culture medium significantly affected choline kinase ( Table 1 ). The addition of inositol alone at final concentrations of 2 and 20 ,ug/ml caused 45 and 58% reductions in the activity, respectively, whereas choline alone at 20 ,ug/ml produced only a 14% reduction. The addition of a combination of inositol (20 ,Lg/ml) and choline (20 ,ug/ml) resulted in a marked reduction in choline kinase activity (77%). Hence, inositol played a major role in the reduction in choline kinase activity, but choline decreased the activity further.
Another notable finding was that the enzyme level varied with the growth phase of cultures, as has been shown for some other regulated phospholipid-synthesizing enzymes (15) . The specific activity of choline kinase increased during the exponential phase, reached a maximum when the A550 of a culture was about 3 (for the absorbances of cultures, see Materials and Methods), and then decreased gradually. Furthermore, the response to inositol and choline was more significant in the exponential phase than it was in the stationary phase. The enzyme became less responsive when the A550 of a culture exceeded 2. This accounts for our failure to detect significant changes in choline kinase activity in response to inositol and choline supplementation in our previous study (37) , in which we used stationary-phase cells.
The addition of 0.5 and 5 mM inositol to the assay mixture had virtually no effect on the partially purified enzyme, the activities being 102 and 103% of the control value, respectively. A 1:1 mixture of the extracts prepared from cells cultured in the presence and absence of inositol plus choline an average specific activity of choline kinase. Hence, the reduction in choline kinase activity observed here was not due to a direct effect of inositol on the enzyme, nor was it due to the production of an inhibitor in the supplemented cells.
We also examined the effects of inositol and choline on the other enzymes in the CDP-choline pathway. Wild-type cells were grown to the mid-logarithmic phase in the presence or absence of inositol and choline, and then the responses of cholinephosphate cytidylyltransferase and cholinephosphotransferase were compared with that of choline kinase. The activities of cholinephosphate cytidylyltransferase and cholinephosphotransferase were affected to much lesser extents by inositol and choline ( Table 2) .
Preparation of an anti-choline kinase antibody. We next tried to determine whether the observed changes in the choline kinase activity were associated with changes in the enzyme amount. As yeast choline kinase has not yet been purified to homogeneity, we used the previously cloned choline kinase gene, CKI, for the preparation of an anticholine kinase antibody. To this end, we constructed a lacZ-CKI fusion gene, as shown diagrammatically in Fig. 1 to the lacZ gene. The resulting hybrid gene encoded a 1,453-amino acid protein comprising residues 153 to 582 of yeast choline kinase joined to 3-galactosidase at its carboxyl-terminal Gly (originally Lys, but changed to Gly through the above construction). This plasmid, pGK1, was introduced into E. coli JM103. The transformant was grown and then treated with isopropyl-D-thiogalactoside to induce the production of the 170-kDa ,-galactosidase-choline kinase fusion protein. The protein was extracted from the cells with 4 M urea by the method of Germino et al. (9), purified by polyacrylamide gel electrophoresis, and then used to immunize a rabbit. The immune serum thus obtained neutralized choline kinase in yeast cell extracts (Fig. 2) were cultured, and then their 4,000 x g supernatants were prepared. To minimize protein degradation, cells were disrupted in the presence of protease inhibitors, PMSF and benzamidine, and the extracts were mixed with Laemmli sample buffer (24) and immediately heated at 100°C for 3 min. The samples were then subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the gel was blotted onto a nitrocellulose membrane. The blot was treated with the affinity-purified anti-choline kinase antibody, and then immunoreactive bands were visualized by using the protein A-peroxidase system. Several immunoreactive respectively. The numbers to the left of the gel in panel A denote the positions of the following protein standards: bovine serum albumin. ovalbumin, rabbit muscle glyceraldehyde-3-phosphate dehydrogenase, bovine erythrocyte carbonic anhydrase, trypsinogen, and cx-lactoalbumin. Symbols: A, location of the enzyme; A, bands thought to be the hydrolytic products.
bands were detected (Fig. 3A) . The following observations led us to conclude that the 66-kDa band was choline kinase. First, this band was not observed for the extract from the cki null mutant (lane 1) but was detectable for the wild-type extract (lane 2). Second, this protein was present in a large amount in the choline kinase overproducer, which carried multiple copies of the CKI gene (lane 3). Its molecular weight was very close to that predicted from the nucleotide sequence of CKI (66,316) (16) as well as to that reported by Brostrom and Browning (4) for their partially purified enzyme preparation (67 kDa). Several minor bands detected on the blot (Fig. 3, A) were thought to be due to proteolytic products of the enzyme.
Decrease in enzyme amount in response to inositol and choline. To examine the effect of inositol and choline on the enzyme amount, we performed similar immunoblot analyses on extracts obtained from cells grown in the presence or absence of inositol and choline. The unsupplemented cells (lane 1) contained severalfold more 66-kDa protein than the supplemented cells (Fig. 3B, lane 2) . Thus, the abovementioned reduction in choline kinase activity caused by inositol and choline was correlated with a decrease in the enzyme amount.
Effect of inositol and choline on choline kinase mRNA abundance. The abundance of choline kinase mRNA was analyzed by Northern Analysis of the expression of CKI with the lacZ reporter gene. We examined the expression of the choline kinase gene using lacZ as a reporter gene. A fusion gene was constructed which contained the 5'-flanking region (308 base pairs) and N-terminal sequence (amino acids 1 to 30) of CKI followed by the in-frame lacZ coding region (Fig. 5) . We transformed a Ieu2 strain, D451-3, with the pCKZ1 plasmid carrying this fusion gene as well as LEU2. The resultant transformant, D451-3(pCKZ1), was grown in M-i medium with or without inositol and choline, and then P-galactosidase activity was assayed. The specific activities in the supplemented and unsupplemented cells were 72 and 285 U (for definition of the 3-galactosidase unit, see Materials and Methods), respectively, proving that the fusion gene was fully responsive to inositol and choline. Hence, this fusion gene contained the entire regulatory sequence of CKI.
We next used this fusion gene for studying the derepression of CKI. The transformant carrying pCKZ1 was precultured in the presence of inositol and choline and then shifted to a new medium with different supplementation for further culture. The change in ,-galactosidase activity was monitored by removing cells from the culture at different times and permeabilizing them and then assaying the enzyme activity. The specific activity increased with time after the removal of inositol and choline, reaching a maximum at 6 h (Fig. 6) . However, when choline was added to the culture medium, the highest level was somewhat lower. Inositol greatly inhibited restoration of the activity. When both inositol and choline were present, the activity did not increase at all. These results are quite consistent with those obtained above and strongly suggest that the transcription of the yeast choline kinase gene is regulated by inositol and choline.
DISCUSSION
The results presented here show that yeast choline kinase, the initial enzyme in the CDP-choline pathway, is regulated at the level of mRNA abundance by inositol and choline. As in the case of other regulated enzymes in yeast phospholipid synthesis, such as phosphatidylethanolamine methyltransferase (37), phospholipid methyltransferase (38), CDP-diacylglycerol synthase (14) , phosphatidylserine synthase (22) , and inositol-1-phosphate synthase (12) , choline kinase is maximally repressed when both inositol and choline are added to the culture medium, but when added separately, inositol has a greater effect than choline. Thus, the control of choline kinase and that of the other key enzymes in phospholipid synthesis have common features. This suggests that the expression of choline kinase is controlled by a genetic mechanism similar to that of the above enzymes. In this context, it would be interesting to examine the control of choline kinase in mutants with pleiotropic defects in the regulation of phospholipid synthesis (22, 25) .
The present results show that the concept of the coordinate regulation of phospholipid synthesis can be extended to the CDP-choline pathway. On the basis of disruption of the choline kinase gene as well as expression of the gene in E. coli cells, we have previously shown that choline kinase accounts for most of the ethanolamine kinase activity in yeast cells (16) . Therefore, the current data indicate that the CDP-ethanolamine pathway is subject to repression by inositol and choline as well.
At present, it is not known whether repression is the sole mechanism for the regulation of choline kinase. Because our previous survey revealed the occurrence of putative phosphorylation sites (Arg-Arg-X-Ser) in the primary sequence of choline kinase predicted from the nucleotide sequence of the CKI gene, the possibility may be considered that yeast choline kinase is subject to regulation through covalent modification of the enzyme, such as phosphorylation, as in the case of phosphatidylserine synthase (21) .
